4th Annual Pharmacovigilance & Risk Management Strategies Summit

Pharmacovigilance is taking on a new form and landscape coming into the 21st century. Many different factors are moulding and shaping the terrain through regulations, collaborations and countries standardising regulations to meet global compliance along with the rapid digital revolution unfolding throughout pharma, it is high time for those in regulatory affairs and research.

We will be taking two days to discover insights from top professionals leading the transformation in pharmacovigilance to deliver the latest in developments in regulation, collaborations, detection methods and overcoming digital challenges with solid solutions for all those in the field of drug safety.

We are looking forward to your participation in this engaging Summit in Berlin this coming November!

Key Practical Learning Points of the Summit:

  • Digital mechanisms and implementations
  • Risk management planning and remediation strategies
  • Potentials and best practices in signal management
  • PV and data management
  • Social media and digital technologies
  • Collaborative progression and advancement in research
  • Latest innovations and trends in drug safety

Who should attend:

Chief Executives, Vice Presidents, Directors, Qualified Persons Responsible, Department Heads, Leaders and Managers specialising in:

  • Pharmacovigilance
  • Drug Safety
  • Risk Management
  • RMPs
  • Safety Management
  • Safety Surveillance
  • Patient Safety
  • Drug Development
  • GPvP
  • PV Inspection & Audit
  • Signal Management
  • Signal Detection
  • Clinical Trials
  • Clinical Development
  • Safety Evaluation
  • Safety Databases
  • Regulatory Affairs
  • Regulatory Submissions
  • Clinical Research
  • Assurance & Compliance
  • Quality Assurance
  • Data Analysis
  • Pharmacoepidemiology
  • Medical Information
  • Health Outcomes
  • Clinical Data Management
  • MedDRA
  • PV Agreements
  • PSMF
  • CAPA
  • Medical Affairs
  • Adverse Drug Reactions